FMAGX
Price
$15.87
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
GAFFX
Price
$82.17
Change
-$0.15 (-0.18%)
Updated
Nov 13 closing price
Ad is loading...

FMAGX vs GAFFX

Header iconFMAGX vs GAFFX Comparison
Open Charts FMAGX vs GAFFXBanner chart's image
Fidelity Magellan
Price$15.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F3
Price$82.17
Change-$0.15 (-0.18%)
VolumeN/A
CapitalizationN/A
FMAGX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMAGX vs. GAFFX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMAGX is a Buy and GAFFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 306B vs. FMAGX (35.9B). GAFFX pays higher dividends than FMAGX: GAFFX (0.75) vs FMAGX (0.33). FMAGX was incepted earlier than GAFFX: FMAGX (62 years) vs GAFFX (8 years). FMAGX is a more actively managed with annual turnover of: 86.00 vs. GAFFX (31.00). FMAGX has a lower initial minimum investment than GAFFX: FMAGX (0) vs GAFFX (1000000). FMAGX annual gain was more profitable for investors over the last year : 34.08 vs. GAFFX (31.73). GAFFX return over 5 years is better than : 58.45 vs. FMAGX (42.88).
FMAGXGAFFXFMAGX / GAFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence62 years8 years-
Gain YTD28.98330.11996%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets35.9B306B12%
Annual Yield % from dividends0.330.7544%
Returns for 1 year34.0831.73107%
Returns for 3 years1.51-0.68-221%
Returns for 5 years42.8858.4573%
Returns for 10 years63.57N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHX3.400.06
+1.80%
PHX Minerals
BLTE82.231.08
+1.33%
Belite Bio
Z74.670.32
+0.43%
Zillow Group
MCBS34.22-0.59
-1.69%
MetroCity Bankshares
CNSP0.12N/A
-3.92%
CNS Pharmaceuticals Inc